Sympathetic overactivity in dialysis patients—Underappreciated and clinically consequential

Cardiovascular morbidity and mortality remain frustratingly common in dialysis patients. A dearth of established evidence‐based treatment calls for alternative therapeutic avenues to be embraced. Sympathetic hyperactivity, predominantly due to afferent nerve signaling from the diseased native kidney...

Full description

Saved in:
Bibliographic Details
Published inSeminars in dialysis Vol. 32; no. 3; pp. 255 - 265
Main Authors Hoye, Neil A., Wilson, Luke C., Jardine, David L., Walker, Robert J.
Format Journal Article
LanguageEnglish
Published United States 01.05.2019
Subjects
Cardiovascular Diseases - epidemiology
Cardiovascular Diseases - physiopathology
Comorbidity
Global Health
Humans
Kidney - innervation
Kidney Failure, Chronic - epidemiology
Kidney Failure, Chronic - physiopathology
Kidney Failure, Chronic - therapy
Renal Dialysis - adverse effects
Risk Factors
Survival Rate
Sympathetic Nervous System - physiopathology
Online AccessGet full text

Cover

More Information
Summary:Cardiovascular morbidity and mortality remain frustratingly common in dialysis patients. A dearth of established evidence‐based treatment calls for alternative therapeutic avenues to be embraced. Sympathetic hyperactivity, predominantly due to afferent nerve signaling from the diseased native kidneys, has been established to be prognostic in the dialysis population for over 15 years. Despite this, tangible therapeutic interventions have, to date, been unsuccessful and the outlook for patients remains poor. This narrative review summarizes established experimental and clinical data, highlighting recent developments, and proposes why interventions to ameliorate sympathetic hyperactivity may well be beneficial for this high‐risk population.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0894-0959
1525-139X
DOI:10.1111/sdi.12756